Related Experiment Video
Updated: Jun 16, 2025

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
Male hypogonadism: pathogenesis, diagnosis, and management
Nipun Lakshitha De Silva1, Nikoleta Papanikolaou2, Mathis Grossmann3
1Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Faculty of Medicine, General Sir John Kotelawala Defence University, Colombo, Sri Lanka.
Testosterone therapy may improve sexual function in men with functional hypogonadism. While generally safe in the short term, evidence for preventing fractures or type 2 diabetes is insufficient.
Area of Science:
- Endocrinology
- Men's Health
- Reproductive Medicine
Background:
- Organic male hypogonadism from hypothalamic-pituitary-testicular (HPT) pathology is well-managed with testosterone replacement.
- Controversy exists regarding testosterone use in symptomatic men with low testosterone due to non-gonadal factors (functional hypogonadism) without clear HPT axis pathology.
- Health optimization is the primary management for functional hypogonadism.
Purpose of the Study:
- To review the pathogenesis and diagnosis of male hypogonadism.
- To critically appraise the evidence for testosterone therapy in functional hypogonadism.
- To discuss the safety and efficacy of testosterone in specific patient populations.
Main Methods:
- Review of large clinical trials and meta-analyses on testosterone therapy.
- Analysis of data concerning cardiovascular and prostate cancer risks.
- Evaluation of evidence for testosterone's effects on bone mineral density and insulin sensitivity.
Main Results:
- Testosterone therapy shows modest, statistically significant improvements in sexual function for men with functional hypogonadism.
- Short- to medium-term risks for cardiovascular events and prostate cancer were not increased.
- Bone mineral density and insulin sensitivity improved, but evidence for fracture or type 2 diabetes prevention remains insufficient.
Conclusions:
- Testosterone therapy can benefit sexual function in functional hypogonadism, with acceptable short-term safety profiles.
- Further research is needed to establish long-term safety and efficacy for fracture and type 2 diabetes prevention.
- Management of functional hypogonadism should prioritize health optimization alongside considering testosterone therapy.
Related Concept Videos
Infertility in Males
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Testosterone: Functions and Regulation
Menopause
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
Testes: Gross Anatomy
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...

